Interferon β therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis

Armando Sena, R. Pedrosa, V. Ferret-Sena, M. J. Cascais, R. Roque, C. Araújo, R. Couderc

Resultado de pesquisa: ???type-name??????researchoutput.researchoutputtypes.contributiontojournal.article???revisão de pares

8 Citações (Scopus)

Resumo

Serum ferritin levels have been found to be increased in patients with active progressive multiple sclerosis (MS). However, its levels are reported to be unchanged in stable and in active relapsing-remitting (RR) form of the disease. No research to date has assessed the influence of interferon β (IFN-β) on ferritin concentrations. In this study, serum ferritin levels were measured in 43 individuals with RR-MS and 38 age- and sex-matched control volunteers. There were no significant differences between controls and patients under stable and untreated conditions. In patients at 12 months after the beginning of IFN-β therapy, ferritin levels were higher in women and in men, in comparison with baseline (71.4 ± 58.6 vs 43.4 ± 29.9 ng/mL, P = 0.0006 and 216.0 ± 124.3 vs 127.8 ± 74.9 ng/mL, P = 0.0022, respectively). These results suggest that larger prospective studies are required to evaluate the role of serum ferritin in MS and its potential usefulness in monitoring responses to immunomodulatory therapies.

Idioma original???core.languages.en_GB???
Páginas (de-até)857-859
Número de páginas3
RevistaMultiple Sclerosis Journal
Volume14
Número de emissão6
DOIs
Estado da publicação???researchoutput.status.published??? - jul. 2008
Publicado externamenteSim

Impressão digital

Mergulhe nos tópicos de investigação de “Interferon β therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis“. Em conjunto formam uma impressão digital única.

Citar isto